UCM-05194 is a selective agonist of the LPA1 receptor, primarily targeting neuropathic pain pathways. This compound exhibits potent activity by triggering LPA1-mediated cellular effects, leading to receptor internalization and functional inactivation in primary sensory neurons. UCM-05194 effectively reduces pain perception in in vivo models, making it a valuable tool for investigating mechanisms underlying progressive systemic diseases and potential therapeutic applications in pain management.
UCM-05194 is a selective agonist of the LPA1 receptor, primarily targeting neuropathic pain pathways. This compound exhibits potent activity by triggering LPA1-mediated cellular effects, leading to receptor internalization and functional inactivation in primary sensory neurons. UCM-05194 effectively reduces pain perception in in vivo models, making it a valuable tool for investigating mechanisms underlying progressive systemic diseases and potential therapeutic applications in pain management.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
